Capricor Therapeutics, Inc. - Common Stock — 貸借対照表 (NASDAQ:CAPR)

Financials

総資産 34.62 M41.33 M50.09 M58.73 M170.48 M355.95 M 負債合計 6.42 M9.96 M38.31 M36.13 M25.02 M50.16 M 純資産合計 28.2 M31.37 M11.79 M22.6 M145.46 M305.79 M 負債および純資産合計 34.62 M41.33 M50.09 M58.73 M170.48 M355.95 M 有利子負債合計 318.16 K03.38 M3.38 M—— 純負債 -32.35 M-34.89 M-38.02 M-36.12 M——

ニュース

Capricor Therapeutics, Inc. (CAPR) Q1 2026 Earnings Call Transcript

Capricor Therapeutics, Inc. (CAPR) Presents at 2026 MDA Clinical & Scientific Conference - Slideshow (NASDAQ:CAPR) 2026-03-13

Capricor: Moving To 'Buy' Rating As New PDUFA Date Is Set For Deramiocel (NASDAQ:CAPR)

Cantor Fitzgerald、決算発表後もCapricor株の投資判断を維持

Cantor Fitzgerald reiterates Capricor stock rating after earnings

Capricor Therapeutics, Inc. (CAPR) Q4 2025 Earnings Call Transcript

Capricor Therapeutics、2025年第4四半期決算でEPS予想を下回る

Earnings call transcript: Capricor Therapeutics Q4 2025 misses EPS forecasts

Capricor Therapeuticsが第4四半期決算で予想を下回り下落

Capricor Therapeutics falls on Q4 earnings miss

FDAがderamiocelの審査を再開、Capricorの決算発表が控える

Capricor earnings on deck after FDA resumes deramiocel review